Staying fit and injury-free is essential for maintaining an active lifestyle - especially when you’re over 40. And the more active you are, the better your quality of life tends to be. But here’s the ...

Los Angeles, California, USA, July 20th, 2026, FinanceWireClinical education and consulting platform Regen Therapy has ...

Vision is one of the most crucial human senses, yet more than 300 million people worldwide are at risk of vision loss due to various retinal diseases. While recent advancements in retinal disease ...

"What should never change is the commitment to helping people heal so they can keep doing the things they love.” ...

A stem cell therapy treatment developed by Duke-NUS Medical School researchers for heart failure has shown promising results in preclinical trials. These cells, when transplanted into an injured heart ...

BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to commence in Q4 2025 SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical ...

Regenerative therapy to treat heart failure is more effective when the mitochondria of the regenerative cells are activated prior to treatment. Heart failure stands as a leading cause of mortality ...

SEATTLE & CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Aurion Biotech, whose mission is to restore vision to millions of patients with life-changing regenerative therapies, today announced that the U.S.

Emmecell receives FDA RMAT designation for EO2002, advancing development of its regenerative cell therapy for corneal endothelial disease.

A Japanese biotechnology company developing what could become the world's first tooth-regeneration therapy has secured fresh funding to accelerate clinical trials. Kyoto-based Toregem BioPharma ...

A new review published in Genes & Diseases highlights macrophage-targeted therapy as a promising frontier in cardiac regeneration and myocardial repair. The findings underscore the critical role of ...